DOJ Launches Task Force on Healthcare Monopolies: Will It Make A Difference?
The U.S. Department of Justice recently launched a task force on healthcare monopolies. Experts have varying opinions on how it will impact the healthcare industry.
Teva, Glenmark To Pay $255M, Divest Cholesterol Drug to Settle DOJ Price Fixing Charges
Generic drugmakers Teva and Glenmark recently became the sixth and seventh drugmakers to resolve criminal charges as a result of the DOJ’s yearslong investigation into generic drug price fixing. The settlement agreement requires both companies to pay hefty fines as well as divest their drug lines for pravastatin, a widely used statin that lowers cholesterol.
The Impact Brands: Empowering Wellness Through Natural and Holistic Solutions
In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means.
Recoveries down under federal False Claims Act but likely to rise again
Covid-19 may have hampered investigations and led authorities to shift resources to more obvious frauds, attorneys said. But the pandemic also created new targets to investigate, including telemedicine and CARES Act funding.
Purdue to plead guilty, pay $8.3B deal to resolve opioid charges
In addition to monetary damages and the guilty pleas, the government is seeking to transform the maker of OxyContin into a public benefit company that would fund efforts to curb opioid abuse and give away drugs to prevent overdose deaths.
Florida man convicted in $1.3B Medicare and Medicaid fraud scheme
After an eight-week trial, Philip Esformes was found guilty for his role in a fraud scheme that involved more than $1.3 billion in fraudulent claims to Medicare and Medicaid for services that weren't provided, weren't medically necessary or were procured through the payment of kickbacks.
Four men, seven companies indicted for $1B telemedicine fraud scheme
The indictment alleges that as part of the scheme, which ran from June 2015 to April 2018, the defendants submitted no less than $931 million in fraudulent claims for payment.
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
eClinicalWorks to pay $155 million to settle false claims suit
eClinicalWorks and some of its employees will pay $155 million to settle claims that the EHR vendor misrepresented the capabilities of its software and paid kickbacks to certain customers in exchange for promoting its product.
Court upholds decision to block $54 billion Anthem-Cigna merger (updated)
There's been a new development in the Anthem-Cigna merger saga: On Friday, a U.S. appeals court upheld a lower court's earlier decision to block the $54 billion deal.
Mylan settles EpiPen Medicaid rebate case for $465M, stock jumps
Mylan settled with the U.S. Department of Justice to head off potential Medicaid liability claims by federal and state governments.
DOJ questions McKesson-Change Healthcare venture (Updated)
The U.S. Deparment of Justice is requesting more information from McKesson and Change Healthcare before signing off on the two companies' plans to combine health IT operations into a new, $3.4 billion business.
At ViVE 2024, Panelists Share Prior Authorization Progress and Frustration in Payer Insights Program
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.
Aetna threatened to leave Obamacare over merger opposition
Aetna had denied any link between the ACA exit and the antitrust lawsuit, but a letter that surfaced this week from Chairman and CEO Mark Bertolini to the Justice Department shows otherwise.
Alere under Medicare/Medicaid fraud investigation (updated)
The investigation into potential fraud could put the brakes on the planned multibillion-dollar acquisition of Alere by Abbott Laboratories.
Record $1B Medicare fraud? It’s Florida’s unofficial state sport
It's the largest single criminal healthcare fraud case the Justice Department has ever brought against individuals.
DOJ sues to block Anthem-Cigna and Aetna-Humana mergers (updated)
The companies disagreed, though some more strongly than others. All four have vowed to defend their planned mergers in court.
Morning Read: DOJ claims ‘largest takedown ever’ of $900M in Medicare fraud
Also, a replacement brought in for striking nurses at Allina Health has gone home, opioid use soars and Kentucky's governor outlines his Medicaid rollback plan.